Article Versions Notes

Banaszkiewicz M, Pietrasik A, Florczyk M, Kędzierski P, Piłka M, Mańczak R, Kochman J, Opolski G, Torbicki A, Kurzyna M, et al. Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty. Diagnostics. 2021; 11(1):133. https://doi.org/10.3390/diagnostics11010133

Banaszkiewicz, Marta, Arkadiusz Pietrasik, Michał Florczyk, Piotr Kędzierski, Michał Piłka, Rafał Mańczak, Janusz Kochman, Grzegorz Opolski, Adam Torbicki, Marcin Kurzyna, and et al. 2021. "Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty" Diagnostics 11, no. 1: 133. https://doi.org/10.3390/diagnostics11010133

Banaszkiewicz, M., Pietrasik, A., Florczyk, M., Kędzierski, P., Piłka, M., Mańczak, R., Kochman, J., Opolski, G., Torbicki, A., Kurzyna, M., & Darocha, S. (2021). Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty. Diagnostics, 11(1), 133. https://doi.org/10.3390/diagnostics11010133